Eutilex.Co.,Ltd is a biotechnology company operating within the biopharmaceutical industry, specializing in the development of immunotherapeutic anti-cancer therapies and antibodies. The company focuses on treating malignant diseases, particularly cancer, and claims to use its proprietary 4-1BB platform technology to enhance immune responses against cancer cells.
Headquarters
1401, 25, Gasan Digital 1-Ro, Geumcheon-Gu
Seoul; Seoul;
Contact Details: Purchase the Eutilex Co.,Ltd. report to view the information.
Website: http://www.eutilex.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service